Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers
Clinical trial NCT02259959 · COMPLETED
Trial details
- NCT number
- NCT02259959
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2007-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.